Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Forum Health Products Limited

Forum Health Products Limited, Betchworth House, 57/65 Station Road, Redhill, Surrey, RH1 1DL
Telephone: +44 (0)1737 857 782
Fax: +44 (0) 1737 857701
WWW: http://www.forum.co.uk
Medical Information Direct Line: 0500 455 456
Customer Care direct line: 0500 455 456

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 16/01/2012
SPC Fybogel Mebeverine

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 16/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
Date of revision of text on the SPC:   10-Jan-2012
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Acute Porphyria warning was included in this section
Updated on 19/10/2011 and displayed until 16/01/2012
Reasons for adding or updating:
  • Change to section 4.3 - Contraindications
Date of revision of text on the SPC:   31-Aug-2011
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
to include additional contraindication - paralytic ileus
Updated on 02/08/2010 and displayed until 19/10/2011
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.8 - Undesirable Effects
  • Change to section 6.1 - List of Excipients
  • Change to section 6. 4 - Special Precautions for Storage
Date of revision of text on the SPC:   04-Dec-2007
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 4.4 - Special Warnings and Precautions for Use: Change to amount of potassium contained per sachet.
Section 4.8 - Undesirable Effects: More effects added
Section 6.1 - List of Excipients: Extra excipient added
Section 6.4 - Special Precautions for Storage: wording altered.
Updated on 31/05/2006 and displayed until 02/08/2010
Reasons for adding or updating:
  • Change to section 10 (date of (partial) revision of the text
Date of revision of text on the SPC:   01/11/05
Legal Category:   GSL/P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 10: The date of revision of the text has changed.

Updated on 27/09/2004 and displayed until 31/05/2006
Reasons for adding or updating:
  • SPC Retired pending re-submission
  • Improved Electronic Presentation
Updated on 29/09/2003 and displayed until 27/09/2004
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 01/10/2002 and displayed until 29/09/2003
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 28/08/2001 and displayed until 01/10/2002
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 23/08/2001 and displayed until 28/08/2001
Reasons for adding or updating:
  • Change to separate SPCs covering individual presentations
Updated on 21/08/2001 and displayed until 23/08/2001
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Updated on 06/09/1999 and displayed until 21/08/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  ispaghula husk
  mebeverine hydrochloride